Details for Luxembourg Supplementary Protection Certificate: LUC00050
✉ Email this page to a colleague
Luxembourg Supplementary Protection Certificate: LUC00050
Country | Patent Number | Supplementary Protection Certificate | SPC Country | SPC Description | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 2041177 | LUC00050 | Luxembourg | PRODUCT NAME: SARILUMAB ET SES DERIVES PHARMACEUTIQUEMENT ACCEPTABLES (KEVZARA); AUTHORISATION NUMBER AND DATE: EU/1/17/1196 20170627 | ⤷ Try a Trial |
>Country | >Patent Number | >Supplementary Protection Certificate | >SPC Country | >SPC Description | >SPC Expiration |